|2001||BSc (Microbiology), Bombay University, Mumbai, India|
|2004||MSc (Biological Sciences), Indian Institute of Science, Bangalore, India|
|2004 - 2010||PhD work in Biology, Indian Institute of Science, Bangalore, India|
|2009 - 2014||Postdoctoral Fellow at ETH, Zurich, Switzerland|
|2014 - present||Group Leader, Max Planck Institute of Immunobiology and Epigenetics Freiburg|
You are here
Inhibitors of several epigenetic regulators are potent in treating leukaemia. Our work has shown that the molecular chaperone Heat-shock protein 90 (Hsp90) binds chromatin and stabilises key chromatin factors including the Mixed Lineage Leukaemia protein. We hypothesise that destabilising epigenetic regulators by inhibiting Hsp90 will be beneficial in controlling leukaemia. We shall identify the oncogenic network of proteins stabilised by Hsp90 at chromatin and define the genome-wide location of Hsp90 binding in leukaemic cells.